|
US 6,982,084 B2 |
|
Prevention and treatment of amyloidogenic disease |
Dale B. Schenk, Burlingame, Calif. (US) |
Assigned to NeuraLab Limited, (Bermuda) |
Filed on Mar. 31, 2004, as Appl. No. 10/815,404. |
Application 09/723927 is a division of application No. 09/201430, filed on Nov. 30, 1998, granted, now 6,787,523. |
Application 10/815404 is a continuation of application No. 09/723927, filed on Nov. 28, 2000, granted, now 6,787,138. |
Claims priority of provisional application 60/080970, filed on Apr. 07, 1998. |
Claims priority of provisional application 60/067740, filed on Dec. 02, 1997. |
Prior Publication US 2005/0031629 A1, Feb. 10, 2005 |
This patent is subject to a terminal disclaimer. |
Int. Cl. A61K 38/00 (2006.01); A61K 39/00 (2006.01); A61K 39/39 (2006.01)
|